DS-1971a

DRUG5 trials

Sponsors

Daiichi Sankyo

Conditions

DiabetesHealthyNeuropathic Pain

Phase 1

Multiple Dose Study of DS-1971a

CompletedNCT02190058

Daiichi SankyoHealthy

Start: 2014-07-31End: 2014-11-30Updated: 2018-12-24

Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a

CompletedNCT02261376

Daiichi SankyoHealthy

Start: 2014-09-30End: 2014-11-30Updated: 2018-12-24

A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

CompletedNCT02473627

Daiichi SankyoHealthy

Start: 2015-05-31End: 2015-07-31Updated: 2015-11-05

Multiple Dose Study of D1971a in Healthy Volunteers

CompletedNCT02564861

Daiichi SankyoHealthy

Start: 2015-09-30End: 2015-12-31Updated: 2017-04-28

Phase 2

Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

WithdrawnNCT02673866

Daiichi SankyoDiabetes, Neuropathic Pain

Start: 2016-02-29End: 2017-02-28Updated: 2016-07-27